DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ALBITIAZOLIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ALBITIAZOLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
HKM715W3UT
Molecule Type:
Small molecule
Molecular Formula:
C24H42N2O2S2+2
Molecular Weight:
454.75
AlogP:
4.67
PSA:
48.22
HBD:
2.0
HBA:
#RotB:
17.0
Source:
EZLOPITANT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
EZLOPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
3L098A8MPY
Molecule Type:
Small molecule
Molecular Formula:
C31H38N2O
Molecular Weight:
454.66
AlogP:
6.2
PSA:
24.5
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SILIBININ
2
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder; Hepatitis C; Liver Failure; Prostatic Neoplasms, Castration-Resistant
Unknown
SILIBININ
×
Maximum Phase:
2
First Approval:
None
UNII:
4RKY41TBTF
Molecule Type:
Small molecule
Molecular Formula:
C25H22O10
Molecular Weight:
482.44
AlogP:
2.36
PSA:
155.14
HBD:
5.0
HBA:
#RotB:
4.0
Source:
AMG-337
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma; Esophageal Neoplasms; Neoplasms; Sarcoma, Clear Cell; Stomach Neoplasms
Hepatocyte growth factor receptor inhibitor
AMG-337
×
Maximum Phase:
2
First Approval:
None
UNII:
08WG8S0L8D
Molecule Type:
Small molecule
Molecular Formula:
C23H22FN7O3
Molecular Weight:
463.47
AlogP:
2.61
PSA:
101.36
HBD:
0.0
HBA:
#RotB:
7.0
Source:
STRONTIUM
2
Small molecule
Investigational
Unknown
Unknown
Osteoporosis; Pain
Unknown
STRONTIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
YZS2RPE8LE
Molecule Type:
Small molecule
Molecular Formula:
H2Sr
Molecular Weight:
89.64
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DIMIRACETAM
2
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
DIMIRACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
4AW7F70MZO
Molecule Type:
Small molecule
Molecular Formula:
C6H8N2O2
Molecular Weight:
140.14
AlogP:
-0.94
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
0.0
Source:
REVEXEPRIDE
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Serotonin 4 (5-HT4) receptor agonist
REVEXEPRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
8C63R2Y02M
Molecule Type:
Small molecule
Molecular Formula:
C21H32ClN3O4
Molecular Weight:
425.96
AlogP:
2.08
PSA:
97.05
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GEDATOLISIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Breast Neoplasms
PI3-kinase class I inhibitor
GEDATOLISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
96265TNH2R
Molecule Type:
Small molecule
Molecular Formula:
C32H41N9O4
Molecular Weight:
615.74
AlogP:
3.02
PSA:
128.29
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LY2623091
2
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension; Renal Insufficiency, Chronic
Mineralocorticoid receptor antagonist
LY2623091
×
Maximum Phase:
2
First Approval:
None
UNII:
6FHZ595FNM
Molecule Type:
Small molecule
Molecular Formula:
C30H30FN5O3
Molecular Weight:
527.6
AlogP:
4.46
PSA:
97.87
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TAS-108
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Estrogen receptor alpha antagonist
TAS-108
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
C39H55NO10
Molecular Weight:
697.87
AlogP:
7.43
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PHENCYNONATE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Motion Sickness
Unknown
PHENCYNONATE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
54F576E38V
Molecule Type:
Small molecule
Molecular Formula:
C22H32ClNO3
Molecular Weight:
393.96
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NRX-101
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NRX-101
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY1067197
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Adenosine A1 receptor agonist
BAY1067197
×
Maximum Phase:
2
First Approval:
None
UNII:
IV690462VZ
Molecule Type:
Small molecule
Molecular Formula:
C35H34ClN7O4S2
Molecular Weight:
716.29
AlogP:
5.94
PSA:
167.25
HBD:
2.0
HBA:
#RotB:
13.0
Source:
LUVADAXISTAT
2
Small molecule
Investigational
Unknown
Unknown
Friedreich Ataxia; Schizophrenia
Unknown
LUVADAXISTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
76IC00YRVR
Molecule Type:
Small molecule
Molecular Formula:
C13H11F3N2O2
Molecular Weight:
284.24
AlogP:
2.28
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ERITORAN
2
Small molecule
Investigational
Unknown
Unknown
Insulin Resistance; Influenza, Human; Pneumonia; Severe Acute Respiratory Syndrome
Unknown
ERITORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
551541VI0Y
Molecule Type:
Small molecule
Molecular Formula:
C66H126N2O19P2
Molecular Weight:
1313.68
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD-1480
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasms; Primary Myelofibrosis; Stomach Neoplasms; Thrombocythemia, Essential
Tyrosine-protein kinase JAK2 inhibitor
AZD-1480
×
Maximum Phase:
2
First Approval:
None
UNII:
KL2Z2TLF01
Molecule Type:
Small molecule
Molecular Formula:
C14H14ClFN8
Molecular Weight:
348.77
AlogP:
3.01
PSA:
104.3
HBD:
3.0
HBA:
#RotB:
5.0
Source:
UDONITRECTAG
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UDONITRECTAG
×
Maximum Phase:
2
First Approval:
None
UNII:
2GOW9TT6AD
Molecule Type:
Small molecule
Molecular Formula:
C20H19NO5
Molecular Weight:
353.37
AlogP:
1.83
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MILVEXIAN
2
Small molecule
Investigational
Unknown
Unknown
Thrombosis; Acute Coronary Syndrome; Atrial Fibrillation
Coagulation factor XI inhibitor
MILVEXIAN
×
Maximum Phase:
2
First Approval:
None
UNII:
0W79NDQ608
Molecule Type:
Small molecule
Molecular Formula:
C28H23Cl2F2N9O2
Molecular Weight:
626.46
AlogP:
5.8
PSA:
125.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FORODESINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, T-Cell, Cutaneous
Unknown
FORODESINE
×
Maximum Phase:
2
First Approval:
None
UNII:
426X066ELK
Molecule Type:
Small molecule
Molecular Formula:
C11H14N4O4
Molecular Weight:
266.26
AlogP:
-2.02
PSA:
134.26
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AT-9283
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Lymphoma, Non-Hodgkin; Neoplasms; Multiple Myeloma
Serine/threonine-protein kinase Aurora-A inhibitor
AT-9283
×
Maximum Phase:
2
First Approval:
None
UNII:
XAV9KYN9WL
Molecule Type:
Small molecule
Molecular Formula:
C19H23N7O2
Molecular Weight:
381.44
AlogP:
2.07
PSA:
110.96
HBD:
4.0
HBA:
#RotB:
5.0
Source:
ETHYL ISOTHIOCYANATE
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms
Unknown
ETHYL ISOTHIOCYANATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3284MJ2T8P
Molecule Type:
Small molecule
Molecular Formula:
C3H5NS
Molecular Weight:
87.15
AlogP:
1.11
PSA:
12.36
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ENECADIN
2
Small molecule
Investigational
Unknown
Unknown
Stroke
Unknown
ENECADIN
×
Maximum Phase:
2
First Approval:
None
UNII:
VR034VW8OG
Molecule Type:
Small molecule
Molecular Formula:
C21H28FN3O
Molecular Weight:
357.47
AlogP:
4.63
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
8.0
Source:
DALPICICLIB
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Melanoma; Stomach Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Nasopharyngeal Carcinoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Sarcoma; Breast Neoplasms
Unknown
DALPICICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
5ZHA5P4PFX
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O2
Molecular Weight:
446.56
AlogP:
4.02
PSA:
101.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DAIDZEIN
2
Small molecule
Investigational
Unknown
Unknown
Osteoporosis
Unknown
DAIDZEIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6287WC5J2L
Molecule Type:
Small molecule
Molecular Formula:
C15H10O4
Molecular Weight:
254.24
AlogP:
2.87
PSA:
70.67
HBD:
2.0
HBA:
#RotB:
1.0
Source:
IMISOPASEM MANGANESE
2
Small molecule
Investigational
Unknown
Unknown
Hypotension
SOD mimic (antioxidant)
IMISOPASEM MANGANESE
×
Maximum Phase:
2
First Approval:
None
UNII:
2Q6R3259KS
Molecule Type:
Small molecule
Molecular Formula:
C21H35Cl2MnN5
Molecular Weight:
483.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CETILISTAT
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Gastric lipase inhibitor
CETILISTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
LC5G1JUA39
Molecule Type:
Small molecule
Molecular Formula:
C25H39NO3
Molecular Weight:
401.59
AlogP:
7.36
PSA:
52.33
HBD:
0.0
HBA:
#RotB:
16.0
Source:
DIHYDREXIDINE
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
DIHYDREXIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
32D64VH037
Molecule Type:
Small molecule
Molecular Formula:
C17H17NO2
Molecular Weight:
267.33
AlogP:
2.65
PSA:
52.49
HBD:
3.0
HBA:
#RotB:
0.0
Source:
TMC-647055
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
RNA-directed RNA polymerase inhibitor
TMC-647055
×
Maximum Phase:
2
First Approval:
None
UNII:
11BD024G7J
Molecule Type:
Small molecule
Molecular Formula:
C32H38N4O6S
Molecular Weight:
606.75
AlogP:
4.16
PSA:
110.18
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DRF-10945
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor alpha agonist
DRF-10945
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XEN-D0501
2
Small molecule
Investigational
Unknown
Unknown
Cough; Diabetes Mellitus, Type 2; Pulmonary Disease, Chronic Obstructive
Vanilloid receptor antagonist
XEN-D0501
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-18038683
2
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder, Major
Serotonin 7 (5-HT7) receptor antagonist
JNJ-18038683
×
Maximum Phase:
2
First Approval:
None
UNII:
9UKQ1NQ8YX
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN3
Molecular Weight:
337.85
AlogP:
3.94
PSA:
29.85
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CPI-0610
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CPI-0610
×
Maximum Phase:
2
First Approval:
None
UNII:
306QR91I9R
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN3O2
Molecular Weight:
365.82
AlogP:
4.07
PSA:
81.48
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BIRICODAR DICITRATE
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms
Unknown
BIRICODAR DICITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
9WQP0L619L
Molecule Type:
Small molecule
Molecular Formula:
C46H57N3O21
Molecular Weight:
987.96
AlogP:
5.02
PSA:
117.15
HBD:
0.0
HBA:
#RotB:
15.0
Source:
VAROGLUTAMSTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
VAROGLUTAMSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
E3DSH8LL4L
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O2
Molecular Weight:
336.4
AlogP:
3.62
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MEM 3454
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MEM 3454
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
122
123
124
125
126
127
128
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA